Medical specialties

Mobile Health Stands Behind Immunization Awareness Month This August in NYS

Retrieved on: 
Wednesday, August 4, 2021
Vaccination, Medical specialties, Immune system, Immunization, Health care, Health, Health observances, World Health Organization

As New York commemorates August as Immunization Awareness Month, Mobile Health is on the frontlines as it drives vaccines to employers, employees, families, and hard-to-reach populations across the country.

Key Points: 
  • As New York commemorates August as Immunization Awareness Month, Mobile Health is on the frontlines as it drives vaccines to employers, employees, families, and hard-to-reach populations across the country.
  • Mobile Health works to bring vaccines directly to New Yorkers as the state commemorates Immunization Awareness Month.
  • In New York, Senator Gustavo Rivera's efforts and leadership culminated in the adoption of Immunization Awareness Month.
  • Mobile Health encourages individuals, families, and employers to let New York State's Immunization Awareness Month be the perfect opportunity to renew their focus not only on immunizations but overall health and wellness.

Experts Demystify Artificial Disc Replacement For Patients

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Surgery, Neurosurgery, Clinical medicine, Intervertebral disc arthroplasty, Thomas Schuler, Spinal stenosis

Experts answer all your questions about artificial disc replacement in a free patient webinar series at spinehealth.org.

Key Points: 
  • Experts answer all your questions about artificial disc replacement in a free patient webinar series at spinehealth.org.
  • The 3-part webinar series has two panels focused on cervical (neck) disc replacement and one panel centered on lumbar (low back) disc replacement.
  • "Our goal is to ensure patients are educated and empowered by information and knowledge as they journey through any kind of spinal health issue, including artificial disc replacement surgery," said Dr. Rita Roy, CEO of the NSHF.
  • Their powerful patient community frequently gets the opportunity to hear from those on the cutting edge of artificial disc replacement and other vital surgeries and treatments.

Item 9 Labs to Host its Third Quarter Fiscal Year 2021 Earnings Call on August 17 at 11:00 a.m. ET

Retrieved on: 
Wednesday, August 4, 2021
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medical specialties, Clinical medicine, Medicine

Item 9 Labs CEOAndrew Bowdenand CFOBobby Mikkelsenwill host the conference call.

Key Points: 
  • Item 9 Labs CEOAndrew Bowdenand CFOBobby Mikkelsenwill host the conference call.
  • A telephonic replay of the conference call will also be available until Tuesday, August 31, 2021 via the following call-in numbers:
    About Item 9 Labs Corp.
  • The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories.
  • Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.

National Kidney Foundation (NKF) and American Society of Nephrology (ASN) Statement on Patient Access to New Drug Treatment Options

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Medicine, Clinical medicine, Kidney diseases, Organ failure, Nephrology, Membrane technology, Kidney failure, Kidney disease, Kidney, Dialysis, Kidney Research UK

Three entirely new classes of drugs now exist that can modify the progression of kidney disease.

Key Points: 
  • Three entirely new classes of drugs now exist that can modify the progression of kidney disease.
  • In simple terms, more interventions are available than ever before that can keep people with kidney disease alive and untethered to a dialysis machine.
  • Heart disease is the most common cause of death for people with kidney disease.
  • It is more common for people with kidney disease to die of heart disease than it is for them to progress to kidney failure.

Jackson Hospital Continues to Lead by Adding New Non-Invasive Ventilation (NIV) Products; ReddyPort™ Elbow and NIV Maintenance for Oral Care

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Health care, Health, Non-invasive ventilation, Niv, Intensive care medicine, Respiratory therapy, Mechanical ventilation

Patients on NIV often experience physical discomforts that can impede well-being during NIV treatment, including dry mouth and phlegm build-up.

Key Points: 
  • Patients on NIV often experience physical discomforts that can impede well-being during NIV treatment, including dry mouth and phlegm build-up.
  • NIV treatment clinical studies conclude mask intolerance is a major cause of overall NIV failure2, resulting in increased length of hospital stay and poor outcomes.
  • ReddyPort products help us provide consistent oral care, maintain patients on NIV, and improve satisfaction for both patients and staff.
  • ReddyPort products promote non-invasive ventilation (NIV) success and better care experiences for patients on NIV, providing solutions to help improve satisfaction, reduce risk and cost, enable efficient workflows, and enhance quality of care.

University Products LLC Offers The Only Vaccine to Help Mitigate Annual Anaplasmosis Outbreaks in Cattle Herds

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Vaccination, Vaccine, Virology, Anaplasmosis, Clinical medicine, Medicine, Vaccines

Developed by Gene Luther, D.V.M., Ph.D., the University Products vaccine has been widely deployed since 2000 in multiple U.S. states and Puerto Rico.

Key Points: 
  • Developed by Gene Luther, D.V.M., Ph.D., the University Products vaccine has been widely deployed since 2000 in multiple U.S. states and Puerto Rico.
  • According to Healthy Farms/Health Agriculture , not all cattle infected with anaplasmosis die, but diagnosing them is important to prevent a full outbreak.
  • Treatment usually involves repeated rounds of antibiotics along with supportive care to help increase the survival rate of infected cattle.
  • "Our vaccine packet gives detailed instructions to ranchers and producers on how to help prevent a full outbreak," said vaccine creator, Dr. Luther.

Papa & Barkley Taps Bo Becker, CPG Veteran as Chief Marketing Officer

Retrieved on: 
Wednesday, August 4, 2021
Pinball, Professional and Amateur Pinball Association, Becker, Cannabis, Barkley, Medical specialties, Clinical medicine, Medicine

EUREKA, Calif., Aug. 4, 2021 /PRNewswire/ -- Papa & Barkley, the #1 cannabis wellness company for topicals and tinctures in California, announced today the appointment of Bo Becker as its new Chief Marketing Officer.

Key Points: 
  • EUREKA, Calif., Aug. 4, 2021 /PRNewswire/ -- Papa & Barkley, the #1 cannabis wellness company for topicals and tinctures in California, announced today the appointment of Bo Becker as its new Chief Marketing Officer.
  • Becker has spent 16 years in marketing, holding several executive roles at CPG nutrition and wellness companies.
  • Evelyn Wang, CEO of Papa & Barkley says, "Papa & Barkley has always stood out amongst the competitive set of cannabis brands as the gold standard for trust and efficacy.
  • says Bo Becker, Chief Marketing Officer at Papa & Barkley.

Quell Therapeutics to Present at the 2021 Wedbush Pacgrow Healthcare Virtual Conference

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Clinical medicine, Medicine, Immunology, Immune system, Regulatory T cell, Liver transplantation, Autoimmunity, Immunosuppression

LONDON and BOSTON, Aug. 4, 2021 /PRNewswire/ --Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that Iain McGill, Chief Executive Officer of Quell Therapeutics, will participate in a panel discussion, Out of Body Experience - Transplant: Two Genotypes Living in Harmony, at the Wedbush Pacgrow Healthcare Virtual Conference on Wednesday, August 11, 2021 at 7:55 p.m. BST (2:55 p.m.

Key Points: 
  • LONDON and BOSTON, Aug. 4, 2021 /PRNewswire/ --Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that Iain McGill, Chief Executive Officer of Quell Therapeutics, will participate in a panel discussion, Out of Body Experience - Transplant: Two Genotypes Living in Harmony, at the Wedbush Pacgrow Healthcare Virtual Conference on Wednesday, August 11, 2021 at 7:55 p.m. BST (2:55 p.m.
  • Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aim to harness, direct and optimize their immune suppressive properties to address serious medical conditions driven by the immune system.
  • Quell's lead candidate QEL-001 is being developed to induce operational tolerance following liver transplantation, with the potential to protect the post-transplant liver without the need for chronic immunosuppressive medications.
  • Quell is also advancing additional programs in neuroinflammatory and autoimmune diseases.

Quell Therapeutics to Present at the 2021 Wedbush Pacgrow Healthcare Virtual Conference

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Clinical medicine, Medicine, Immunology, Immune system, Regulatory T cell, Liver transplantation, Autoimmunity, Immunosuppression

LONDON and BOSTON, Aug. 4, 2021 /PRNewswire/ --Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that Iain McGill, Chief Executive Officer of Quell Therapeutics, will participate in a panel discussion, Out of Body Experience - Transplant: Two Genotypes Living in Harmony, at the Wedbush Pacgrow Healthcare Virtual Conference on Wednesday, August 11, 2021 at 7:55 p.m. BST (2:55 p.m.

Key Points: 
  • LONDON and BOSTON, Aug. 4, 2021 /PRNewswire/ --Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced that Iain McGill, Chief Executive Officer of Quell Therapeutics, will participate in a panel discussion, Out of Body Experience - Transplant: Two Genotypes Living in Harmony, at the Wedbush Pacgrow Healthcare Virtual Conference on Wednesday, August 11, 2021 at 7:55 p.m. BST (2:55 p.m.
  • Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aim to harness, direct and optimize their immune suppressive properties to address serious medical conditions driven by the immune system.
  • Quell's lead candidate QEL-001 is being developed to induce operational tolerance following liver transplantation, with the potential to protect the post-transplant liver without the need for chronic immunosuppressive medications.
  • Quell is also advancing additional programs in neuroinflammatory and autoimmune diseases.

Athletico Physical Therapy Opens in Frisco (Teel & Eldorado)

Retrieved on: 
Wednesday, August 4, 2021
Medical specialties, Health, Rehabilitation medicine, Sports medicine, Manual therapy, Physical exercise, Physical therapy, Athletico Physical Therapy, Therapy, Telehealth

FRISCO, Texas, Aug. 4, 2021 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Frisco and is conveniently located in front of the Sprouts Farmers Market in the West Towne Center Shopping center.

Key Points: 
  • FRISCO, Texas, Aug. 4, 2021 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Frisco and is conveniently located in front of the Sprouts Farmers Market in the West Towne Center Shopping center.
  • In addition to in-clinic treatment at the Frisco (Teel & Eldorado) clinic, Athletico is also offering telehealth virtual treatment options where patients can connect with a Physical Therapist through a secure online video chat.
  • Services available at Athletico Frisco (Teel & Eldorado) include:
    Physical therapy Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury.
  • We also offer joint replacement therapy, headache treatment, concussion therapy and more.